Long Island & Queens Vitreo Retinal Consultants, P.C.

🔍 Unlocking the mysteries of color perception! Researchers at the University of Rochester utilized adaptive optics to delve into the intricate workings of the retina, shedding light on how we perceive color. Learn more: https://brnw.ch/21wKS8N

Are these newly found rare cells a missing link in color perception? University of Rochester researchers have identified elusive retinal ganglion cells in the fovea that could explain how humans see color.

Vitreoretinal Consultants of New York (VRCNY) is proud to support the American Diabetes Association (ADA). The ADA's annual Tour De Cure on Saturday, June 8, 2024, in Riverhead, NY at Hallock Farm was a huge success! Thank you to the ADA for allowing us to ride united in your cause. We look forward to next year already!

🔬 Dive into the forefront of retinal care with Vitreoretinal Consultants of NY! Join our nationally recognized clinical trials focusing on age-related macular degeneration, diabetic eye complications, and more. For details on current trials and enrollment, contact Kristen D'Amore at [email protected] or call 516-466-0390 ext. 222. Learn more: https://brnw.ch/21wKP9K

👁️ Discover the potential of topical therapy in treating full-thickness macular holes! A recent study led by Dr. Jessie Wang highlights promising results, with over a third of patients experiencing closure. This research sheds light on factors influencing efficacy, offering hope for improved treatment outcomes.
https://brnw.ch/21wKKLU

Topical therapy's impact on macular hole closure Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Join our team at VRC! We're currently hiring dedicated professionals to deliver top-notch vitreoretinal care. If you're passionate about making a difference in patients' lives, apply now: https://brnw.ch/21wKFpO

Discover the surprising role of blinking in visual perception! A recent study from the University of Rochester reveals that blinks aren't just about moistening the eyes—they actively reshape how we process visual information. Learn more: https://brnw.ch/21wKrtC

Ever Wonder Why We Blink So Much? - Neuroscience News A new study reveals the critical role of blinking in visual perception.

🌍🚭 In recognition of World No To***co Day on May 31, we're helping to shed light on the hidden dangers of smoking. With over 4,000 toxic chemicals, smoking isn't just harmful to your lungs—it's a major threat to your eyes, leading to conditions like cataracts, dry eyes, and even blindness. Protect your vision, say no to to***co!

***coDay

Reminder that we're upgrading to a brand-new office space! Starting June 1, 2024, you can find us at 720 White Plains Road (3rd Floor), Scarsdale, NY.

On this Memorial Day, we honor and remember the brave individuals who made the ultimate sacrifice in service to our country. Their courage and sacrifice will never be forgotten. 🇺🇸

Stay up-to-date with the latest advancements in ophthalmology by participating in clinical trials. We conduct clinical trials for various eye conditions, offering potential new treatments to those in need. Learn more: https://brnw.ch/21wK5jw

A reminder that we're upgrading to a brand-new office space! Starting June 1, 2024, you can find us at 720 White Plains Road (3rd Floor), Scarsdale, NY.

Big news from Adverum Biotechnologies! Early results from the LUNA Phase 2 trial on Ixo-vec for wet AMD look promising. Patients are seeing ongoing benefits, and it's shaping up to be a game-changer in managing this condition. Learn more: https://brnw.ch/21wJXYg 💉👁️

Adverum Biotechnologies releases positive preliminary efficacy, safety data from LUNA Phase 2 trial of Ixo-vec in patients with wet AMD Preliminary safety data support a favorable benefit-risk profile at both dose levels. The preliminary efficacy and safety data trending similar to or better than the OPTIC study, in which patients continue to see ongoing clinical benefit through at least 3 years.

🌟 Ready to make a difference in the field of retina care? Join our dynamic team and be a part of revolutionizing patient care! Apply to be a vital part of our team: https://brnw.ch/21wJRft

Your eye health is our priority, and we're here to make scheduling your consultation as seamless as possible. Our patient-focused approach means you can trust us to provide personalized care tailored to your needs. Whether you're booking online or reaching out to our dedicated staff, rest assured that your vision is in good hands. Learn more: https://brnw.ch/21wJMxc

In a groundbreaking study, NIH researchers have unveiled the 3D organization of genetic material during key developmental stages of human retinal formation using lab-grown retinal organoids. This discovery may pave the way for understanding clinical traits in various eye diseases, shedding light on the dynamic process of chromatin architecture in regulating gene expression. https://brnw.ch/21wJBa9

👁️🧬

Study details how genes in retina get regulated during development A genome topology map of human retina development lays the foundation for understanding diverse clinical phenotypes in simple and complex eye diseases.

🎉 Exciting Announcement! We're thrilled to share that we're upgrading to a brand-new office space! Starting June 1, 2024, you can find us at 720 White Plains Road (3rd Floor), Scarsdale, NY.

Meet Stephanie whose journey, from her Stargardt disease diagnosis to becoming a prominent advocate for disability awareness, showcases her unwavering strength and determination. Her willingness to share her experiences has illuminated the path for many navigating similar journeys. We salute Stephanie's dedication to raising awareness and providing invaluable support to those with visual impairments. Learn more: https://brnw.ch/21wJpQN

🌟

VRC's own James Soque, imaging expert, will be hosting a webinar on Wednesday, 5/31, entitled "Fundus Photography for Clinical Trials Imaging." Click the link here if you are interested in joining: https://brnw.ch/21wJlSv

Researchers have developed All_Aboard, a mobile app designed to assist blind or visually impaired individuals in finding bus stops with greater accuracy than mainstream GPS systems like Google Maps. In a recent study, All_Aboard achieved a success rate of 93%, significantly outperforming Google Maps, and could be a game-changer for those relying on public transportation. Learn more: https://brnw.ch/21wJkTG

👁️🚌

All_Aboard app assists blind and visually impaired commuters in finding bus stops Massachusetts Eye and Ear researchers came up with a mobile app called All_Aboard, designed to be used along with mainstream GPS systems and focuses on improving micro-navigation.

Vitreoretinal Consultants of New York (VRCNY) is proud to support the American Diabetes Association (ADA)! VRCNY will be riding on Saturday, June 8, 2024, in Riverhead, NY at Hallock Farms for the ADA's Annual Tour De Cure 2024. We look forward to this event!

🌟 Breaking barriers in vision care! Kiora Pharmaceuticals unveils game-changing results for KIO-301, a revolutionary molecule offering hope to retinitis pigmentosa patients with ultra-low vision or blindness. Significant improvements in visual field, acuity, and functional vision pave the way for a brighter future in eye health. 👁️
https://brnw.ch/21wIWSl

AAO 2023: Kiora’s small molecule photoswitch shows meaningful vision improvements in blind patients diagnosed with RP The company presented topline Phase I/II first-in-human results at the 127th AAO annual meeting in San Francisco, demonstrating significant improvement in visual field, in concordance with trended improvements in visual acuity and functional vision.

We're on a mission to save sight, with over 35,400 individuals receiving critical care this year alone. Together, we're combating blindness and restoring hope, one patient at a time.

Don't miss out on the April 8 total solar eclipse! 😎 But remember, safety first! The American Academy of Ophthalmology and the American Astronomical Society have teamed up to provide tips on safe viewing. Protect your vision by viewing this infographic: https://brnw.ch/21wIzmL

🌑🔭

Safe Solar Eclipse Viewing - Infographic The American Academy of Ophthalmology and the American Astronomical Society are working together to make sure everyone knows how to watch the coming eclipse safely. Looking directly at the sun, even w

As the 2024 Great American Eclipse approaches on April 8th, it's crucial to prioritize eye safety. Protect your vision with informed viewing practices during this extraordinary celestial event. Explore our comprehensive eclipse fact sheet for essential guidance. Learn more: https://brnw.ch/21wIyaA

🌒🕶️

Special Safety Edition: 2024 Great American Eclipse - Patients - The American Society of Retina Specialists On April 8, 2024, North America will witness a rare total solar eclipse as the moon passes between the sun and the Earth, blocking daylight for several minutes. Weather permitting, it promises to be an incredible event if viewed safely.

Exciting findings reveal a significant link between optical coherence tomography (OCT) scans of the eye and renal pathology. The study highlights the potential of retinal OCT imaging to non-invasively monitor and serve as a prognostic biomarker for kidney injury in patients with chronic kidney disease (CKD). This innovative approach could offer novel insights into tracking kidney health, treatment responses, and predicting outcomes, presenting a promising development for managing CKD. https://brnw.ch/21wIrO1

👁️🔬

OCT retinal scans show the eye-kidney connection The kidney and eye are structurally and functionally similar, and the diseases of the organs may present similarly and via common pathways.

This National Doctors Day, we celebrate our esteemed Retina Specialists! Highly trained and nationally recognized, they lead the way in retinal care with their expertise and dedication. Join us in honoring these exceptional doctors for their invaluable contributions to healthcare.